Bioactivity:

Rifaximin is an orally administered, semi-synthetic, nonsystemic antibiotic derived from rifamycin SV with antibacterial activity. Rifaximin binds to the beta-subunit of bacterial DNA-dependent RNA polymerase, inhibiting bacterial RNA synthesis and bacter

CAS nr:

80621-81-4

Purity:

98%

Molecular Weight:

785,88

SMILES:

CO[C@H]1\C=C\O[C@@]2(C)Oc3c(C2=O)c2c4nc5cc(C)ccn5c4c(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)c(O)c2c(O)c3C

Formula:

C43H51N3O11

Pathway:

Microbiology/Virology,Microbiology/Virology,DNA Damage/DNA Repair,Cell Cycle/Checkpoint

Target:

Antibacterial,Antibiotic,DNA/RNA Synthesis,DNA/RNA Synthesis